Page 1 of Clinical Trials for Adrenergic alpha-2 Receptor Antagonists, 101 Total Matches
- 1Completed
- 2RecruitingLast Updated: January 12, 2012Condition(s): Post-Traumatic Stress Disorder
- 3CompletedLast Updated: March 3, 2008Condition(s): Healthy
- 4CompletedLast Updated: March 3, 2008Condition(s): Erectile Dysfunction
- 5CompletedLast Updated: December 22, 2008Condition(s): Blood Flow Velocity; Autoregulation; Ocular Physiology
- 6Not yet recruitingLast Updated: May 4, 2012Condition(s): Type 2 Diabetes
- 7Active, not recruitingLast Updated: June 28, 2011Condition(s): Autonomic Nervous System Diseases; Orthostatic Hypotension
- 8RecruitingLast Updated: September 15, 2011Condition(s): Healthy
- 9RecruitingLast Updated: May 10, 2012Condition(s): Autonomic Failure; Orthostatic Hypotension
- 10CompletedLast Updated: March 3, 2008Condition(s): Healthy
- 11CompletedLast Updated: August 19, 2011Condition(s): Alcoholism
- 12RecruitingLast Updated: August 24, 2009Condition(s): Depression, Involutional; Major Depresssion
- 13CompletedLast Updated: August 3, 2011Condition(s): Phobic Disorders
- 14Not yet recruitingLast Updated: September 10, 2009Condition(s): Erectile Dysfunction
- 15RecruitingLast Updated: February 21, 2012Condition(s): Heroin Dependence; Opioid-Related Disorders
- 16WithdrawnLast Updated: January 28, 2008Condition(s): Major Depressive Disorder
- 17Completed
- 18RecruitingLast Updated: July 19, 2011Condition(s): Social Anxiety Disorder
- 19CompletedLast Updated: June 23, 2005Condition(s): Lipodystrophy
- 20CompletedLast Updated: March 8, 2012Condition(s): Psychoses, Substance-Induced
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Adrenergic+alpha-2+Receptor+Antagonists
